CAMILLA FLEMATE: Open Payments
NPI 1962638569 · LOS GATOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,337 in 141 payments from 20 companies in 2025. Trend: 2023 $2,652 · 2024 $4,842 · 2025 $4,337
Food & beverage: $4,257Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $704 |
| Janssen Biotech, Inc. | 17 | $516 |
| Galderma Laboratories, L.P. | 13 | $514 |
| GENZYME CORPORATION | 11 | $400 |
| Incyte Corporation | 17 | $377 |
| Arcutis Biotherapeutics, Inc. | 6 | $332 |
| Lilly USA, LLC | 8 | $209 |
| REVANCE THERAPEUTICS, INC. | 4 | $193 |
| Journey Medical Corporation | 2 | $176 |
| Regeneron Healthcare Solutions, Inc. | 9 | $175 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, Opzelura, Zoryve, BOTOX, RINVOQ, TALTZ.
Industry payments across CA — which companies pay providers there.
